DNA X Inc (SONM) FinancialsSONMDNA X Inc

DNA X Inc (SONM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Smartphones, accounting for 50.0% of total sales, equivalent to $8.11M. Other significant revenue streams include Connected solutions and Feature Phones. Understanding this composition is critical for investors evaluating how SONM navigates market cycles within the Phones & Handheld Devices industry.

In the context of the broader market, SONM competes directly with industry leaders such as IVDA and UTSI. With a market capitalization of $5.15M, it holds a significant position in the sector. When comparing efficiency, SONM's gross margin of N/A stands against IVDA's 54.69% and UTSI's 16.21%. Such benchmarking helps identify whether DNA X Inc is trading at a premium or discount relative to its financial performance.

The company reported a gross margin of 11.20% for Q3 2025, indicating some improvement in profitability, although it still faces challenges with net income.